Evidence map›Paper›PMID 10377433›Full record

ArticleProceedings of the National Academy of Sciences of the United States of America1999

Induction of differentiation of pre-NKT cells to mature Valpha14 NKT cells by granulocyte/macrophage colony-stimulating factor.

H Sato, T Nakayama, Y Tanaka, M Yamashita, Y Shibata, E Kondo, Y Saito, M Taniguchi

Open access · greenAbstract read
In one paragraph

Article in Proceedings of the National Academy of Sciences of the United States of America, 1999. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Article
  3. Discovery of NKT cells and development of NKT cell-targeted anti-tumor immunotherapy.Proceedings of the Japan Academy. Series B, Physical and biological sciences · 2015
    Review
  4. Article
  5. Ascites specific inhibition of CD1d-mediated activation of natural killer T cells.Clinical cancer research : an official journal of the American Association for Cancer Research · 2008
    Article
  6. Article
  7. CD1d and invariant NKT cells at the human maternal-fetal interface.Proceedings of the National Academy of Sciences of the United States of America · 2002
    Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 1 institution in 1 country.

H SatoCore Research for Evolutional Science and Technology (CREST), Department of Molecular Immunology, Graduate School of Medicine, Chiba University, Chiba University School of Medicine 1-8-1 Inohana, Chuo-ku, Chiba 260-8670 Japan.
T Nakayama
Y Tanaka
M Yamashita
Y Shibata
E Kondo
Y Saito
M Taniguchi
Chiba University · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Valpha14 NKT cells express an invariant antigen receptor encoded by Valpha14 and Jalpha281 gene segments as well as natural killer (NK) markers, including NK1.1. Here, we describe a precursor population of NKT cells (pre-NKT) that expresses NK1.1, T cell antigen receptor beta, pTalpha, and RAG1/2 but not Valpha14 and surface CD3epsilon. Such pre-NKT cells were differentiated successfully in vitro into mature CD3epsilon+ Valpha14(+) NKT cells by IL-15 and granulocyte/macrophage colony-stimulating factor (GM-CSF) in conjunction with stroma cells. Interestingly, only GM-CSF without stroma cells induced the Valpha14-Jalpha281 gene rearrangement in the pre-NKT cells. This also was confirmed by the findings that the number of mature Valpha14 NKT cells and the frequency of Valpha14-Jalpha281 rearrangements were decreased significantly in the mice lacking a GM-CSF receptor component, common beta-chain. These results suggest a crucial role of GM-CSF in the development of Valpha14 NKT cells in vivo.

Indexed as

AnimalsAntigensAntigens, Differentiation, T-LymphocyteAntigens, LyAntigens, SurfaceCell DifferentiationFlow CytometryGranulocyte-Macrophage Colony-Stimulating FactorKiller Cells, NaturalLectins, C-TypeMiceMice, Inbred C57BLMice, TransgenicNK Cell Lectin-Like Receptor Subfamily BProteinsAntigensAntigens, Differentiation, T-LymphocyteAntigens, LyAntigens, SurfaceGranulocyte-Macrophage Colony-Stimulating FactorKlrb1c protein, mouseLectins, C-TypeNK Cell Lectin-Like Receptor Subfamily BProteins

Identifiers

PMID10377433
PMCPMC22104
OpenAlexW1978494392

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.